ADL 10-0101

ADL 10-0101 Uses, Dosage, Side Effects, Food Interaction and all others data.

ADL 10-0101 is a peripheral kappa opioid agonist analgesic product candidate. Preclinical trials of ADL 10-0101 have suggested that the compound may be effective for the treatment of inflammatory pain, itch and visceral pain. Because ADL 10-0101 does not cross the blood-brain barrier and enter the brain when administered at therapeutic doses, it is expected to avoid central nervous system side effects.

ADL 10-0101 is a peripheral kappa opioid agonist. It cannot cross the blood-brain barrier.

Table Of contents

• ADL 10-0101
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	ADL 10-0101
Generic	ADL 10-0101
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in pain (acute or chronic) and rheumatoid arthritis. Trials are also being conducted for relieving burn pain and dermal itch.

How ADL 10-0101 works

Agonist at peripheral kappa opioid receptors

Innovators Monograph

You find simplified version here ADL 10-0101